Y-mAbs Therapeutics, Inc. (YMAB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:30PM EDT. Market open.
| Previous close | 11.82 |
| Open | 11.78 |
| Bid | 11.91 x 300 |
| Ask | 12.07 x 200 |
| Day's range | 11.76 - 12.47 |
| 52-week range | 4.60 - 20.90 |
| Volume | |
| Avg. volume | 368,985 |
| Market cap | 526.591M |
| Beta (5Y monthly) | 0.77 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2024 Earnings Call Transcript
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2024 Earnings Call Transcript May 8, 2024 Y-mAbs Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to Y-mAbs Therapeutics Inc. Earnings Conference Call for the First Quarter of 2024. […]
- GuruFocus.com
Y-mAbs Therapeutics Inc (YMAB) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
Amidst leadership changes and competitive pressures, Y-mAbs Therapeutics Inc reports robust U.S. sales growth and strategic global expansions.
- Thomson Reuters StreetEvents
Q1 2024 Y-mAbs Therapeutics Inc Earnings Call
Q1 2024 Y-mAbs Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.